BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Concentric Analgesics Forges Important Phase 3 Clinical Relationships for Vocacapsaicin, a Non-Opioid Pain Therapy Targeting TRPV1 Receptor

  Concentric Analgesics, Inc today announced two important Phase 3 clinical relationships for its lead product candidate, vocacapsaicin.

  February 2, 2022

   · 

  5 min read
• Business

  CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)

  CRISPR Therapeutics and ViaCyte, Inc., today announced the first patient has been dosed in the Phase 1 clinical trial of VCTX210.

  February 2, 2022

   · 

  6 min read
• Business

  Evoke Pharma and EVERSANA Extend Commercialization Partnership to Further Support GIMOTI

  Evoke Pharma, Inc. and EVERSANA Life Science Services, today announced the extension of their agreement to continue collaborating on the commercialization and distribution of Gimoti ® (metoclopramide) nasal spray.

  February 2, 2022

   · 

  8 min read
• Biotech Bay

  Juvena Therapeutics Awarded Highly Competitive CIRM Grant To Advance Lead Program, JUV-161, To Treat Myotonic Dystrophy Type 1

  Juvena Therapeutics today announced that the company has been awarded a highly competitive translational grant from the California Institute of Regenerative Medicine (CIRM), totaling $3,906,376.

  February 2, 2022

   · 

  2 min read
• BioMidwest

  Bridge to Life Ltd. Announces First Enrollment and Orthotopic Liver Transplantation in its Pivotal Bridge to HOPE Liver Clinical Trial

  Bridge to Life Ltd. announced first enrollment and orthotopic liver transplantation in its U.S. pivotal Bridge to HOPE Liver Clinical Trial (NCT05045794).

  February 2, 2022

   · 

  4 min read
• Genetown

  Paragonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case

  Paragonix Technologies LUNGguard ™ Used in Record Cross-Country Donor Lung Transplant Case.

  February 2, 2022

   · 

  4 min read
• Pharm Country

  Following LSNE Acquisition, PCI Pharma Services Continues to Expand Sterile Fill-Finish Expertise with State-of-the-Art Equipment

  PCI Pharma Services, a leading global contract development and manufacturing organization, announced the addition of three new exceptional automated sterile fill-finish machines in its San Diego and Melbourne facilities.

  February 2, 2022

   · 

  4 min read
• Deals

  City of Hope Completes Strategic Acquisition of Cancer Treatment Centers of America, Building a National, Integrated Cancer Research and Treatment System With a Singular Focus on Eradicating Cancer

  City of Hope has completed its previously announced acquisition of Cancer Treatment Centers of America (CTCA).

  February 2, 2022

   · 

  3 min read
• Lexaria Reports Potentially Ground-Breaking Findings in Sildenafil Animal Study

  Lexaria Bioscience Corp. announces positive findings in an animal study evaluating DehydraTECH TM processing of the phosphodiesterase inhibitor.

  February 2, 2022

   · 

  5 min read
• Business

  Bexion Pharmaceuticals Announces Leadership Additions

  Bexion Pharmaceuticals today announced key leadership changes, including the appointment of Richard “Scott” Shively as the Company’s President and Chief Executive Officer, and member of the board of directors.

  February 2, 2022

   · 

  4 min read